Valuation Haemonetics Corporation
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.91 USD | +1.43% |
|
+2.23% | -0.30% |
| 06-29 | Haemonetics Corporation(NYSE:HAE) added to Russell 2000 Value Benchmark | CI |
| 06-29 | Haemonetics Corporation(NYSE:HAE) added to Russell 2000 Value-Defensive Index | CI |
Company Valuation: Haemonetics Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,068 | 3,992 | 4,335 | 3,175 | 2,511 | 3,632 | - | - |
| Change | - | 30.13% | 8.58% | -26.76% | -20.89% | 44.61% | - | - |
| Enterprise Value (EV) 1 | 3,582 | 4,473 | 4,335 | 4,093 | 3,490 | 4,304 | 4,016 | 3,708 |
| Change | - | 24.89% | -3.1% | -5.58% | -14.71% | 23.31% | -6.68% | -7.67% |
| P/E | 71.5x | 35.3x | 37.3x | 19.1x | 26.4x | 20.3x | 18x | 15.9x |
| PBR | 4.09x | 4.88x | - | 3.71x | 3.21x | 3.01x | 2.39x | 1.96x |
| PEG | - | 0x | 16.71x | 0.4x | -0.7x | 0.2x | 1.4x | 1.2x |
| Capitalization / Revenue | 3.09x | 3.42x | 3.31x | 2.33x | 1.88x | 2.59x | 2.46x | 2.32x |
| EV / Revenue | 3.61x | 3.83x | 3.31x | 3.01x | 2.62x | 3.07x | 2.72x | 2.37x |
| EV / EBITDA | 12.6x | 14.7x | 11.7x | 9.67x | 7.93x | 9.61x | 8.31x | 6.86x |
| EV / EBIT | 19.1x | 20.5x | 15.7x | 12.5x | 10.3x | 11.8x | 10.2x | 8.69x |
| EV / FCF | - | - | 37.5x | 33.7x | 13.4x | 15x | 14.2x | 12.3x |
| FCF Yield | - | - | 2.66% | 2.96% | 7.46% | 6.67% | 7.02% | 8.14% |
| Dividend per Share 2 | - | - | - | - | - | 2 | - | - |
| Rate of return | - | - | - | - | - | 2.5% | - | - |
| EPS 2 | 0.84 | 2.24 | 2.29 | 3.31 | 2.05 | 3.933 | 4.445 | 5.025 |
| Distribution rate | - | - | - | - | - | 50.8% | - | - |
| Net sales 1 | 993.2 | 1,169 | 1,309 | 1,361 | 1,334 | 1,402 | 1,474 | 1,564 |
| EBITDA 1 | 284.9 | 304.7 | 370.1 | 423.3 | 440.1 | 447.6 | 483.6 | 540.9 |
| EBIT 1 | 187.1 | 218.4 | 276.5 | 326.3 | 338.5 | 364.5 | 393.8 | 426.7 |
| Net income 1 | 43.38 | 115.4 | 117.6 | 167.7 | 97.31 | 176.4 | 203.8 | 229.8 |
| Net Debt 1 | 514.1 | 481.4 | - | 918 | 979.1 | 672.5 | 384.8 | 76.86 |
| Reference price 2 | 60.02 | 79.13 | 85.35 | 63.19 | 54.04 | 79.91 | 79.91 | 79.91 |
| Nbr of stocks (in thousands) | 51,112 | 50,448 | 50,786 | 50,237 | 46,471 | 45,446 | - | - |
| Announcement Date | 10/05/22 | 11/05/23 | 09/05/24 | 08/05/25 | 07/05/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.32x | 3.07x | 9.61x | 2.5% | 3.63B | |
| 29.63x | 4.08x | 15.87x | 2.48% | 182B | |
| 19.11x | 3.34x | 11.74x | 3.53% | 108B | |
| 17.31x | 0.19x | 12.22x | 0.76% | 60.54B | |
| 31.19x | 7.57x | 19.79x | 1.28% | 50.53B | |
| 39.6x | 3.14x | 10.7x | 2.42% | 43.79B | |
| 38.06x | 1.39x | 12.2x | 0.26% | 33.57B | |
| 29.82x | 5.34x | 17.02x | -.--% | 28.31B | |
| 38.63x | 6.76x | 24.22x | 0.27% | 23.31B | |
| 24.05x | 3.51x | 12.63x | 1.21% | 21.28B | |
| Average | 28.77x | 3.84x | 14.60x | 1.47% | 55.48B | |
| Weighted average by Cap. | 27.79x | 3.74x | 14.64x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HAE Stock
- Valuation Haemonetics Corporation
Select your edition
All financial news and data tailored to specific country editions
